Safety Assessment of Dose-Escalated 225Ac-PSMA-617 Radioligand Therapy in Patients with Advanced Metastatic Castration-Resistant Prostate Cancer Following Standard Treatment Failure. Вопр. онкол. [Internet]. 2025 Nov. 5 [cited 2026 Oct. 14];71(5):OF-2520. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/5-25-Safety-Assessment-of